Clinical trial
A Comparison of Indapamide SR 1.5 mg With Hydrochlorothiazide 25 mg, in Combination With an ACE-inhibitor, in Old Patients With Mild to Moderate Renal Insufficiency and Hypertension
NCT01172431 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of Indapamide SR 1.5 mg With Hydrochlorothiazide 25 mg, in Combination With an ACE-inhibitor, in Old Patients With Mild to Moderate Renal Insufficiency and Hypertension
- Lead sponsor
- West China Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- December 31, 2013
- Enrollment
- 240 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.